Loading...

Pacific Blue™ anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_Blue_091207
C57BL/6 mouse splenocytes stained with Pacific Blue™ 30-F11
  • 30-F11_Blue_091207
    C57BL/6 mouse splenocytes stained with Pacific Blue™ 30-F11
Compare all formats See Pacific Blue™ spectral data
Cat # Size Price Quantity Check Availability Save
103125 25 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103126 100 µg 172€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with Pacific Blue™ under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD45 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Pacific Blue™ has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue™ conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Perveen S, et al. 2012. PLoS One. 7:e51945. PubMed
  2. Zabala M, et al. 2020. Cell Stem Cell. 27(2):284-299.e8. PubMed
  3. Barkaway A, et al. 2021. Immunity. . PubMed
  4. Girbl T et al. 2018. Immunity. 49(6):1062-1076 . PubMed
  5. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  6. Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
  7. Ma L, et al. 2009. J Immunol. 183:1044. PubMed
  8. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  9. Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
  10. Quintero H, et al. 2022. Cell Rep. 40:111324. PubMed
  11. Berube A, et al. 2022. Viruses. 14:. PubMed
  12. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  13. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  14. Skowron K, et al. 2016. Sci Rep. 6:35854. PubMed
  15. Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed
  16. Wietecha MS, et al. 2020. Nat Commun. 2.266666667. PubMed
  17. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  18. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  19. Li H, et al. 2022. Cell Rep Med. 3:100554. PubMed
  20. Reinitz F, et al. 2022. Elife. 11:. PubMed
  21. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  22. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  23. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  24. Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed
  25. Fernandes RA, et al. 2020. eLife. 9:e58463.. PubMed
  26. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  27. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  28. Fitzgerald B, et al. 2021. Cell Rep Methods. 1:. PubMed
  29. Súarez-López L, et al. 2021. iScience. 24:103406. PubMed
  30. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  31. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  32. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  33. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  34. Peuhu E, et al. 2017. PLoS One. 12:e0186628. PubMed
  35. Deslyper G, et al. 2021. Parasitology. 148:539. PubMed
  36. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  37. Leimkühler NB, et al. 2020. Cell Stem Cell. 28:637. PubMed
  38. Chan A, et al. 2014. Am J Pathol. 184:1411. PubMed
  39. Scheele C, et al. 2017. Nature. 542:313-317. PubMed
  40. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  41. Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
  42. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  43. Sperber HS, et al. 2020. FASEB J. 14615:34. PubMed
  44. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  45. Nie M, et al. 2016. Cell Death Dis. 7:e2261. PubMed
  46. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  47. Lee C, et al. 2014. Cancer Res. 74:341. PubMed
  48. Shi C, et al. 2010. J Immunol. 184:6266. PubMed
  49. Minatoguchi S, et al. 2022. Sci Rep. 12:5389. PubMed
  50. Karaman S, et al. 2022. J Exp Med. 219:. PubMed
  51. Guo HF, et al. 2021. Commun Biol. 4:482. PubMed
  52. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  53. Wan W, et al. 2013. Cardiovasc Res. 97:580. PubMed
  54. Dubey LK, et al. 2019. Cell Rep. 27:2442. PubMed
  55. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  56. An J, et al. 2022. iScience. 25:103570. PubMed
  57. Jeong SJ, et al. 2021. Autophagy. 17:3740. PubMed
  58. Menzel L, et al. 2022. STAR Protoc. 3:101267. PubMed
  59. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  60. Lovisa S, et al. 2020. Sci Signal. 13:00. PubMed
  61. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  62. Rosen D, et al. 2016. J Infect Dis. 213: 649 - 658. PubMed
  63. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  64. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  65. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  66. Hartwig T et al. 2018. Cell reports. 25(13):3564-3572 . PubMed
  67. Bignami F, et al. 2017. Acta Ophthalmol. 95:e641. PubMed
  68. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  69. Mifflin L, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  70. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  71. Cheah M, et al. 2015. Proc Natl Acad Sci U S A. 112:4725. PubMed
  72. Cheng Q, et al. 2020. Nat Nanotechnol. 0.842361111. PubMed
  73. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  74. Thiriot A et al. 2017. BMC biology. 15(1):45 . PubMed
  75. Taniguchi H, et al. 2022. Cell Rep. 39:110814. PubMed
  76. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  77. Mender I, et al. 2020. Cancer Cell. 38(3):400-411.e6. PubMed
  78. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  79. McCoy S 2015. Am J Physiol Lung Cell Mol Physiol. 309: L463-L474. PubMed
  80. Frasca D, et al. 2020. Front Immunol. 11:328. PubMed
  81. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  82. Cai S et al. 2017. Cell stem cell. 20(2):247-260 . PubMed
  83. Lee DH, et al. 2019. PLoS One. 14:e0215727. PubMed
  84. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  85. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  86. Chang J, et al. 2016. J Am Soc Nephrol. 10.1681/ASN.2015121356. PubMed
  87. Hiebert P et al. 2018. Developmental cell. 46(2):145-161 . PubMed
  88. Diéguez–Hurtado R, et al. 2019. Nat Commun. 10:2817. PubMed
  89. Lee S et al. 2017. Cell host & microbe. 22(4):449-459 . PubMed
  90. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  91. Gusarova GA, et al. 2021. JCI Insight. 6: . PubMed
  92. Tan X, et al. 2021. Sci Adv. 7: . PubMed
  93. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  94. Sungur C, et al. 2013. Proc Natl Acad Sci U S A. 110:7401. PubMed
  95. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  96. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  97. Williams JW, et al. 2017. Circ Res. 121:662. PubMed
  98. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  99. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  100. Mantilla-Rojas C, et al. 2022. Cancers (Basel). 14:. PubMed
  101. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
  102. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  103. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  104. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  105. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  106. Nishida C, et al. 2012. Blood. 119:5405. PubMed
  107. Spix B, et al. 2022. Nat Commun. 13:318. PubMed
  108. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  109. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  110. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  111. Huang S, et al. 2020. Cell. 184(2):441-459.e25. PubMed
  112. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  113. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  114. Vacca F, et al. 2020. eLife. 9:e54017.. PubMed
  115. Chia JSJ, et al. 2018. Nutrients. 1.313194444. PubMed
  116. Li Y et al. 2018. Cell Stem Cell. 23(2):181-192 . PubMed
  117. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  118. Engblom C, et al. 2017. Science. 358:6367. PubMed
  119. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  120. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  121. McAndrews KM, et al. 2021. J Biol Chem. 296:100523. PubMed
  122. Choudhary S, et al. 2012. J Virol. 86:114. PubMed
  123. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  124. Kato K, et al. 2018. Nat Commun. 48:120. PubMed
  125. Li C, et al. 2018. Cell. 174:285. PubMed
  126. Iwata TN, et al. 2018. Mol Cancer Ther. 17:1494. PubMed
  127. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  128. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  129. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  130. Pfirschke C, et al. 2020. Cell Rep. 32:108164. PubMed
  131. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  132. Aoto M, et al. 2019. FEBS Open Bio. 9:291. PubMed
  133. Ualiyeva S, et al. 2021. Bio Protoc. 11:e4163. PubMed
  134. Ko FC, et al. 2021. J Bone Miner Res. 36:1510. PubMed
  135. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  136. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  137. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  138. Yao Z, et al. 2020. Cancer Res. 80:1171. PubMed
  139. Stefan KL, et al. 2020. Cell. 1312:183. PubMed
  140. Gomes AM, et al. 2018. Cell Rep. 25:2821. PubMed
  141. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  142. Rui J, et al. 2021. Nat Commun. 12:5074. PubMed
  143. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  144. Tang S, et al. 2022. Virol J. 19:32. PubMed
  145. Chen Y, et al. 2021. Cancer Cell. 39(4):548-565.e6. PubMed
  146. Carson W, et al. 2011. PLoS One. 6:e20385. PubMed
  147. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  148. Forese MG et al. 2019. Glia. 68(1):95-110 . PubMed
  149. Zilionis R et al. 2019. Immunity. 50(5):1317-1334 . PubMed
  150. Tucey TM et al. 2018. Cell metabolism. 27(5):988-1006 . PubMed
  151. Weidner T, et al. 2021. Nat Protoc. 16:3210. PubMed
  152. Yamaguchi T, et al. 2020. Eur J Immunol. 50:110. PubMed
  153. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  154. Fite BZ, et al. 2021. Sci Rep. 11:927. PubMed
  155. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  156. Sasai M, et al. 2021. J Exp Med. 218:. PubMed
  157. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  158. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  159. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  160. Pattabiraman D, et al. 2016. Science. 351: aad3680. PubMed
  161. Borrelli MR, et al. 2020. Stem Cells Transl Med. 1.347916667. PubMed
  162. Hemanthakumar KA, et al. 2021. eLife. 10:00. PubMed
  163. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  164. Eilken H, et al. 2017. Nat Commun. . 10.1038/s41467-017-01738-3. PubMed
  165. Thurlow LR, et al. 2018. Cell Host Microbe. 24:261. PubMed
  166. Avey D et al. 2018. Cell reports. 24(13):3619-3629 . PubMed
  167. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  168. Mahmoudi S, et al. 2019. Nature. 574:553. PubMed
  169. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  170. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  171. Shue YT, et al. 2022. Nat Commun. 13:2690. PubMed
  172. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  173. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  174. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  175. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  176. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed
  177. Jiang Q, et al. 2008. Blood. 112:2858. PubMed
  178. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  179. Barry DM, et al. 2019. Nat Commun. 4.378472222. PubMed
  180. Jorge Domínguez‐Andrés et al. 2017. Immunity. 46(6):1059-1072 . PubMed
  181. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  182. Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed
  183. Shao S, et al. 2020. Proc Natl Acad Sci U S A. 117:8845. PubMed
  184. Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
RRID
AB_493536 (BioLegend Cat. No. 103125)
AB_493535 (BioLegend Cat. No. 103126)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account